World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
61
Citations
14618
World Ranking
11279
National Ranking
4887

Alvaro N.A. Monteiro publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Alvaro N.A. Monteiro sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 243 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Alvaro N.A. Monteiro D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Alvaro N.A. Monteiro sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 61 D-Index — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Alvaro N.A. Monteiro is affiliated with the University of South Florida in the United States and has contributed extensively to the fields of biochemistry, genetics, and molecular biology, with a specific focus in genetics and molecular biology subfields. Their research spans topics including BRCA gene mutations in cancer, genomics and rare diseases, CRISPR and genetic engineering, PARP inhibition in cancer therapy, genetic associations and epidemiology, DNA repair mechanisms, and ovarian cancer diagnosis and treatment.

Their recent publications demonstrate a concentration on variant classification and functional analysis in hereditary cancer genes. Notable papers include:

  • Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel, 2024, published in The American Journal of Human Genetics
  • Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance, 2021, The American Journal of Human Genetics
  • Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation, 2020, Journal of Medical Genetics
  • Norepinephrine-Induced DNA Damage in Ovarian Cancer Cells, 2020, International Journal of Molecular Sciences
  • Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores, 2021, JNCI Journal of the National Cancer Institute

Monteiro's publications are frequently found in well-regarded venues, including:

  • The American Journal of Human Genetics
  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Cancer Research
  • Brazilian Journal of Implantology and Health Sciences

Significant collaborators in Monteiro's research efforts include Fergus J. Couch, Marcy E. Richardson, Thales C. Nepomuceno, Tina Pesaran, and Marcelo A. Carvalho, reflecting partnerships that have contributed to numerous publications.

The scientist's work spans a range of topics central to cancer genetics and molecular pathology. Key research themes include:

  • BRCA gene mutations in cancer
  • Genomics and rare diseases
  • CRISPR and genetic engineering
  • PARP inhibition in cancer therapy
  • Genetic associations and epidemiology
  • DNA repair mechanisms
  • Ovarian cancer diagnosis and treatment

Monteiro's overall publication record covers 98 works in biochemistry, genetics, and molecular biology, alongside 53 in medicine. Their research contributes to an improved understanding of hereditary cancer gene variants, mechanisms of DNA repair, and therapeutic approaches informed by genetic risk factors.

Best Publications

  • Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

    Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson

  • Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

    Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley

  • Evidence for a transcriptional activation function of BRCA1 C-terminal region

    Alvaro N. A. Monteiro;Avery August;Hidesaburo Hanafusa

  • Principles for the post-GWAS functional characterization of cancer risk loci

    Matthew L Freedman;Alvaro N A Monteiro;Simon A Gayther;Simon A Gayther;Gerhard A Coetzee

  • Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2.

    David E. Goldgar;Douglas F. Easton;Amie M. Deffenbaugh;Alvaro N.A. Monteiro

  • BRCA1 regulates p53-dependent gene expression

    Toru Ouchi;Alvaro N. A. Monteiro;Avery August;Stuart A. Aaronson

  • A Systematic Genetic Assessment of 1,433 Sequence Variants of Unknown Clinical Significance in the BRCA1 and BRCA2 Breast Cancer–Predisposition Genes

    Douglas F. Easton;Amie M. Deffenbaugh;Dmitry Pruss;Cynthia Frye

  • Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

    Catherine M Phelan;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Jonathan P Tyrer;Siddhartha P Kar

  • GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

    Paul D.P. Pharoah;Ya Yu Tsai;Susan J. Ramus;Catherine M. Phelan

  • ENIGMA - evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes

    Amanda B. Spurdle;Sue Healey;Andrew Devereau;Frans B L Hogervorst

  • A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS)

    Noralane M. Lindor;Lucia Guidugli;Xianshu Wang;Maxime P. Vallée

  • BRCA1 and BRCA2 genetic testing—pitfalls and recommendations for managing variants of uncertain clinical significance

    D. M. Eccles;G. Mitchell;G. Mitchell;A. N. A. Monteiro;R. Schmutzler

  • Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.

    Siddhartha P. Kar;Jonathan Beesley;Ali Amin Al Olama;Kyriaki Michailidou

  • Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.

    Johan Vallon-Christersson;Charmagne Cayanan;Karin Haraldsson;Niklas Loman

  • A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC

    Michael J. Schell;Mingli Yang;Jamie K. Teer;Fang Yin Lo

  • Biallelic Deleterious BRCA1 Mutations in a Woman with Early-Onset Ovarian Cancer

    Susan M. Domchek;Jiangbo Tang;Jill Stopfer;Dana R. Lilli

  • Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

    Hui Shen;Brooke L. Fridley;Honglin Song;Kate Lawrenson

  • Comprehensive Analysis of Missense Variations in the BRCT Domain of BRCA1 by Structural and Functional Assays

    Megan S. Lee;Ruth Green;Sylvia M. Marsillac;Nicolas Coquelle

  • A guide for functional analysis of BRCA1 variants of uncertain significance

    Gaël A. Millot;Marcelo A. Carvalho;Sandrine M. Caputo;Maaike P.G. Vreeswijk

  • p53 Acetylation Is Crucial for Its Transcription-independent Proapoptotic Functions

    Hirohito Yamaguchi;Nicholas T. Woods;Landon G. Piluso;Heng Huan Lee

Frequent Co-Authors

Joellen M. Schildkraut
Joellen M. Schildkraut University of Virginia
Susan J. Ramus
Susan J. Ramus University of New South Wales
Paul D.P. Pharoah
Paul D.P. Pharoah University of Cambridge
Catherine M. Phelan
Catherine M. Phelan University of South Florida
Ellen L. Goode
Ellen L. Goode Mayo Clinic
Graham G. Giles
Graham G. Giles University of Melbourne
Fergus J. Couch
Fergus J. Couch Mayo Clinic
Thomas A. Sellers
Thomas A. Sellers Oregon Health & Science University
Andrew Berchuck
Andrew Berchuck Duke University
Ian G. Campbell
Ian G. Campbell Peter MacCallum Cancer Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Alvaro N.A. Monteiro

Trending Scientists

Recently Published Articles